Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.21 USD | +10.11% | +17.17% | +26.99% |
02:00pm | Oppenheimer Initiates Capricor Therapeutics at Outperform Rating | MT |
May. 13 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
Business Summary
Number of employees: 102
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Transformative Cell and Exosome-based Therapeutics
100.0
%
| 3 | 100.0 % | 25 | 100.0 % | +886.81% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 3 | 100.0 % | 25 | 100.0 % | +886.81% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Linda Marbán
CEO | Chief Executive Officer | 60 | 13-11-19 |
Anthony Bergmann
DFI | Director of Finance/CFO | 38 | 13-11-19 |
Kristi Elliott
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Karen Krasney
LAW | General Counsel | 71 | 11-12-31 |
General Counsel | 71 | 15-02-27 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Philip Gotwals
BRD | Director/Board Member | 61 | 23-07-20 |
Earl Collier
BRD | Director/Board Member | 76 | 13-11-19 |
George Dunbar
BRD | Director/Board Member | 77 | 13-11-19 |
David Musket
BRD | Director/Board Member | 66 | 13-11-19 |
Frank Litvack
CHM | Chairman | 68 | 11-12-31 |
Karimah Es Sabar
BRD | Director/Board Member | 66 | 21-07-22 |
Linda Marbán
CEO | Chief Executive Officer | 60 | 13-11-19 |
Paul Auwaerter
BRD | Director/Board Member | 62 | 23-07-12 |
Michael Kelliher
BRD | Director/Board Member | 47 | 23-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 31,811,470 | 28,971,840 ( 91.07 %) | 0 | 91.07 % |
Company contact information
Capricor Therapeutics, Inc.
10865 Road to the Cure Suite 150
92121, San Diego
+858 727 1755
http://www.capricor.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.61% | 178M | |
+8.84% | 114B | |
+11.48% | 104B | |
-12.84% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-3.38% | 17.89B | |
+8.01% | 14.28B | |
+34.44% | 12.55B |
- Stock Market
- Equities
- CAPR Stock
- Company Capricor Therapeutics, Inc.